Sirtuin modulators: where are we now? A review of patents from 2015 to 2019.
Epigenetics
aging
cancer
neurodegeneration
sirtuins
small molecule modulators
Journal
Expert opinion on therapeutic patents
ISSN: 1744-7674
Titre abrégé: Expert Opin Ther Pat
Pays: England
ID NLM: 9516419
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
2
4
2020
medline:
5
1
2021
entrez:
2
4
2020
Statut:
ppublish
Résumé
In recent years, sirtuins (SIRTs) gained an increasing consideration because of their multiple key roles in several biological settings such as the regulation of transcription, energetic metabolism, cell cycle progression, and cytodifferentiation, apoptosis, neuro- and cardio-protection, inflammation, cancer onset and progression. Since there is mounting evidence in favor of potential therapeutic applications of SIRT modulators in various age-related disorders, the search about them is quite active.
Identifiants
pubmed: 32228181
doi: 10.1080/13543776.2020.1749264
doi:
Substances chimiques
Sirtuins
EC 3.5.1.-
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM